Tuesday, February 05, 2008

Named Patient Programs: An Overview

Date: 2/5/2008
Length: 00:18:17
Size: 8.37MB

Thought Leader: Natalie Douglas, CEO, IDIS

In this episode, Natalie Douglas provides an introduction to named patient programs, describes the factors that motivate pharmaceutical and biotech companies to implement these programs, and highlights the benefits to the patient as well as the sponsoring company.

Play Full Podcast

Download Related White Paper

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

No comments: